Brief: Achieve Life Sciences Announces Completion Of Enrollment In ORCA-OL Clinical Trial

Achieve Life Sciences

10/10/2024 13:04

Oct 10 (Reuters) - Achieve Life Sciences Inc  ACHV.O :
    * ACHIEVE LIFE SCIENCES ANNOUNCES COMPLETION OF ENROLLMENT
IN
ORCA-OL CLINICAL TRIAL & SUCCESSFUL OUTCOME OF THE FIRST DATA
SAFETY MONITORING COMMITTEE MEETING
    * ACHIEVE LIFE SCIENCES INC - DSMC REVIEW FINDS NO SAFETY
CONCERNS
IN ORCA-OL TRIAL
    * ACHIEVE LIFE SCIENCES INC - TO MEET FDA TO FINALIZE VAPING
CESSATION PLANS
    * ACHIEVE LIFE SCIENCES INC - FDA GRANTS BREAKTHROUGH
THERAPY
DESIGNATION TO CYTISINICLINE
    * ACHIEVE LIFE SCIENCES INC - COMPLETES TWO PHASE 3 TRIALS
AND ONE
PHASE 2 TRIAL

Source text for Eikon:  ID:nGNX7kspc4 
Further company coverage:  ACHV.O 

 ((Reuters.Briefs@thomsonreuters.com;))